Implementation of the World's largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation by Sarma, Haribondhu et al.
Sarma et al. BMC Public Health          (2019) 19:925 
https://doi.org/10.1186/s12889-019-7176-4RESEARCH ARTICLE Open AccessImplementation of the World’s largest
measles-rubella mass vaccination campaign
in Bangladesh: a process evaluation
Haribondhu Sarma1,2* , Ashwin Budden3, Sharmin Khan Luies1, Stephen S. Lim4, Md. Shamsuzzaman1,
Tahmina Sultana1, Julie K. Rajaratnam3, Laura Craw5, Cathy Banwell2, Md. Wazed Ali1 and Md. Jasim Uddin1Abstract
Background: Gavi, the Vaccine Alliance, supported a mass vaccination Measles-Rubella Campaign (MRC) in Bangladesh
during January–February 2014.
Methods: We conducted a mixed-method process evaluation to understand the successes and challenges in
implementation of the MRC. We reviewed documents for the MRC and the immunization programme in
Bangladesh; observed meetings, vaccination sessions, and health facilities; and conducted 58 key informant
interviews, 574 exit interviews with caregivers and 156 brief surveys with stakeholders involved in immunization.
Our theory of Change for vaccination delivery guided our assessment of ideal implementation milestones and
indicators to compare with the actual implementation processes.
Results: We identified challenges relating to country-wide political unrest, administrative and budgetary delays,
shortage of transportation, problems in registration of target populations, and fears about safety of the vaccine.
Despite these issues, a number of elements contributed to the successful launch of the MRC. These included: the
comprehensive design of the campaign; strong partnerships between immunization authorities in the government
system, Alliance partners, and civil society actors; and motivated and skilled health workers at different levels of the
health system.
Conclusions: The successful implementation of the MRC in spite of numerous contextual and operational challenges
demonstrated the adaptive capacity of the national immunization programme and its partners that has positive
implications for future introductions of Gavi-supported vaccines.
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Mass vaccination campaigns are important mechanisms
to control and eliminate infectious diseases in low- and
middle-income countries (LMICs). In recent years,
measles-rubella campaigns (MRCs) have helped countries
achieve their national immunization coverage targets [1–
9]. Global measles control programs have increasingly
used campaigns to supplement routine immunization and
reduce measles-related morbidity [10]. However, measles© The Author(s). 2019 Open Access This artic
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mortality in children, despite the availability of low-cost
vaccines for over 40 years [11].
Prior evaluations of MRCs in different countries have
estimated vaccine coverage [2, 7], described immunization
settings, and waste disposal procedures [5], assessed the
quality of vaccine [12], and documented campaign out-
puts [4]. They called attention to a number of areas for
improvement in campaign operations, including the need
for pre-campaign meetings to foster strong coordination
between national and district levels; timely training, work-
shops, and post-campaign review; planning for adequate
logistics; micro-planning for sub-district and district
levels; and types and duration of vaccination sessions [1,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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mentation of MRCs can be hampered by systemic chal-
lenges that include vaccine availability, political unrest,
and inadequate training for health workers [2, 3, 13].
To reduce the measles and rubella disease burden, the
Expanded Program on Immunization (EPI) in Bangladesh,
managed by the Ministry of Health and Family Welfare
(MoHFW), conducted an MRC from 25 January to 13
February 2014. The national campaign targeted more than
52 million children aged 9months to 14 years. Gavi, the
Vaccine Alliance (commonly known as Gavi) funded the
government to conduct the campaign, which included
planning, training the health workforce, mobilizing de-
mand in communities, and procuring the MR vaccine.
Gavi also supported a Full Country Evaluation (FCE) in
Bangladesh, from 2013 to 2016, to understand and meas-
ure vaccine coverage, barriers to, and drivers of, improve-
ment of the immunization program, with an emphasis on
its contribution of Gavi [14]. The FCE team conducted a
coverage survey in a high performing and a low perform-
ing division in Bangladesh to measure coverage of
Measles-Rubella (MR) vaccination before and after the
MRC [15]. The results of that survey showed significant
improvement of MR vaccination coverage in both the
areas. MR vaccination coverage in high performing div-
ision was 4% before MRC and it increased to 95% after
MRC. In the low-performing division, MR coverage in-
creased from 11 to 85% after MRC [15].
The results of the outcome survey demonstrated the
effectiveness of the MRC. In general, however, outcome
evaluations do not shed light on why and how programs
achieved such successful outcomes, or provide informa-
tion that would aid replication or scale-up of the pro-
gram in other settings. Process evaluations can fill this
knowledge gap by assessing whether program activities
have been implemented as intended [16], and by
highlighting challenges and success and the process that
contributed to them. As part of the FCE, we conducted
a process evaluation of the MRC. It is expected that this
evaluation will provide information for improving the
operations of the immunization programme in
Bangladesh, for ensuring accountability at the country
level to inform the implementation of future vaccination
campaign.Methods
The process evaluation was one of the aspects of a
multi-faceted evaluation of the MRC in Bangladesh. It
employed a cross-sectional, retrospective and mixed
methods study design, covering the full results from in-
puts to impact, to examine the planning and implemen-
tation phases of the MRC. The evaluation framework
entailed inter-related steps: Development of a theory of change which provided
an analytical framework for defining ideal program
implementation milestones and indicators to
compare with the actual processes [17, 18]. Our
theory of change organized the process around a
series of high-level milestones which, ideally, must
be accomplished for the output to be achieved
(Fig. 1). For each milestone of the Theory of Change,
we developed indicators to reflect the fidelity of the
implementation, (i.e. whether the program was de-
livered as intended).
 Process tracking included a document review
(n = 31), observations of immunization stakeholders’
meetings (n = 4) and vaccination sessions (n = 144),
and facility assessments (n = 200). Process tracking,
which was the primary means of monitoring the
progress of the MRC implementation activities,
compared the actual processes with the ideal
processes defined in the Theory of Change. The
document review captured a wide range of written
sources pertaining to all phases of Gavi support. We
obtained documents through direct requests to the
stakeholders; through access to routine distribution
channels, such as email list and web sites; and
through database searches. The documents included
country expressions of interest and applications to
Gavi for support; review- and decision-related corre-
spondences from Gavi; MoHFW planning docu-
ments such as the operational plans of Maternal
Neonatal Child and Adolescent Health, the national
health sector plan (HPNSDP 2011–2016), health
bulletins of the Directorate General of Health Ser-
vices (DGHS), Comprehensive Multi-Year Plan; and
meetings minutes of the interagency coordination
committee and technical sub-committee.
 In-depth key informant interviews (n = 58) with
purposively selected EPI stakeholders, including EPI
managers at different levels of the health system and
representatives from partner organizations and
MoHFW; exit interviews with caregivers (n = 574) of
beneficiary children; and a brief survey (n = 156) of
immunization service providers.
The key informants were national-level stakeholders
who were involved in policy-making; design, planning,
and implementation of the campaign while immunization
stakeholders were direct service providers at the commu-
nity or facility level.
We also conducted root cause analysis [19] to understand
and document how particular challenges and successes
around the MRC implementation have occurred. These in-
volved group exercises through collaborative brainstorming,
critical assessment of evidence gathered (both qualitative
and quantitative), and visual diagramming of causal chains
Figure 1 Theory of Change (ToC) for MRC
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quences to assumed root causes).
These methods were employed to identify and
prioritize gaps in understanding key programmatic chal-
lenges and successes and to further investigate them and
explain their underlying causes.
We implemented the process evaluation at the na-
tional, district, and community levels in both rural and
urban areas of Bangladesh. We purposively selected two
administrative divisions, out of seven in the country,
based on EPI coverage data [20]: Rajshahi (high-per-
forming), with 85.8% of children fully immunized and
Sylhet (low-performing), with 74.8% of children fully im-
munized. The respective population-size (PS) of Rajshahi
and Sylhet division at the time of the evaluation was 18,
484,858 and 9,910,219 [21]. We then selected Joypurhat
District (high-performing), with 88.4% fully vaccinated
(PS = 950,441) from the Rajshahi division and Sylhet Dis-
trict, (low-performing), with 74.9% (PS = 3,434,188) from
the Sylhet division. Similarly, we selected two City
Corporations (Municipality Corporation that act as local
governments): Rajshahi City Corporation (high-performing), with 88.8% fully vaccinated (PS = 449,756)
and Sylhet City Corporation (low-performing), with
62.4% (PS = 531,663) [20, 21]. A detailed explanation of
the selection of study sites has been reported elsewhere
[15].
We collected quantitative data through direct observa-
tions of vaccination sessions, structured exit interviews,
and provider surveys to estimate the proportion of
respondents reporting on the study indicators, such as
mothers’ perceptions on the campaign, their motiva-
tions, and experiences with the healthcare providers re-
garding the services they received from the campaign.
We performed univariate analysis and equality of two
proportions test (Fisher’s exact test/t- test) on these data
and calculated 95% confident intervals (CI) for each esti-
mate (percentage/mean). The confidence interval pre-
sented in the tables calculated considering cluster in
account. After performing Fisher’s exact test for categor-
ical variables and t-test for continuous variables, p-
values were used to demonstrate the statistical differ-
ences between two areas (high-performing and low-
performing).
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qualitative data collection so that we could already iden-
tify informational gaps and saturation points (meaning
that little new information was being gathered on
particular topics [22]). Our analysis followed Patton’s ap-
proach to qualitative evaluation [23], in which we started
with data coding, then proceeded to data reduction, dis-
play, and synthesis and interpretation of data. We used
Atlas-ti software (version 6.2) for managing and analys-
ing qualitative data. We performed root cause analysis
on priority issues and questions that emerged from the
initial analysis to clarify information gaps and confirm
the findings. As part of our root cause analysis, we cre-
ated flowcharts to visually depict the causal chains link-
ing observed challenges and successes in the
implementation of the MRC to their underlying causes.
Results
The MRC in Bangladesh was the largest immunization
campaign in the world to date, reaching roughly a target
of 52 million children aged 9months to < 15 years. Des-
pite a number of challenges, the campaign was imple-
mented successfully due to some key enabling factors.
Detailed findings on challenges and successes are de-
scribed below under four main themes.
Design and availability of funds for MRC
The MoHFW planned to implement the MRC in two-
phases within a three-week campaign period. During the
first phase it carried out vaccination activities in educa-
tional institutions and during the second phase at EPI
facilities. The MoHFW took timely initiatives to develop
and update the MRC implementation process, and up-
dated stakeholders at the sub-national level through
memos and letters. Nevertheless, there were noted gaps
in planning and budgeting line items in the absence of
prior consultation with sub-national stakeholders.
Timely approval and allocation of the MRC funds
depended on inclusion of the campaign budget in the
Operation Plan of Maternal Neonatal Child and Adoles-
cent Health, part of the comprehensive Multi-year Plan
of MoHFW. The comprehensive Multi-year Plan had
already included MR vaccination in the routine EPI
schedule but not as a separate campaign activity. Hence,
Gavi approved the application for support under the
condition that the comprehensive Multi-year Plan and
the respective Operation Plan would be eventually re-
vised by including the MRC. However, without an up-
dated comprehensive Multi-year Plan and Operation
Plan, the budget for implementing the MRC could not
be approved for the country, which led to a delay in
start-up of the MRC. The Minister of the MoHFW
attempted to reduce administrative delays by adjusting
the MRC budget to release funds for disbursement at alladministrative levels (Fig. 2). In response, the EPI
rescheduled the MRC launch from November 2013 to
January 2014.
Figure 2 shows the results of root cause analysis on
the implementation of the MRC. Initially, there were a
number of challenges that delayed the implementation
of the MRC, for example, concern about safe and on-
schedule vaccine transportation, with the root cause be-
ing identified as political unrest. Despite these
challenges, the MRC was implemented in a timely and
successfully manner due to the commitment of partners
organizations such as United Nations Children’s Fund
(UNICEF) and World Health Organization (WHO) that
helped in mitigating to the contingent challenges, des-
pite the political, seasonal and other contexts (Fig. 2).
Once the MoHFW received the decision letter from
Gavi for funding the MRC, Gavi distributed the funds
within the agreed timeframe mentioned in the decision
letter for implementation of the MRC. The funds were
also disbursed in a timely fashion to the district and
sub-district levels. Almost all the service providers re-
ported that they had received their training allowances.
However, key informants at the sub-national level indi-
cated that inadequate funds were allotted for volunteers’
refreshments, which discouraged them from participat-
ing in the MRC vaccination sessions. Concerned health
workers spent their own money to ensure the participa-
tion of the volunteers in the sessions.
Management of micro-planning, logistics, and cold chain
for MR vaccine
The EPI reviewed and updated micro-plans prior to the
campaign. Delayed distribution of micro-planning forms
from national to the sub-national level created stress for
health workers. However, health workers still performed
micro-planning on time as they were motivated to do
the extra work and were able to work beyond normal of-
fice hours; they also used their experiences from previ-
ous immunization campaigns (Fig. 2) to reflect on this
campaign. One community health worker commented:
Registration time was a constraint to our work
efficiency. Allocating at least three months for
registration activities is necessary for these types of
program.
Recurrent political unrest in country posed difficulties
for distributing vaccines and supplies for the MRC.
However, EPI had collected and stored buffer stock of
vaccines at national, district, and sub-district levels. Dur-
ing outbreaks of unrest, the WHO provided vehicles to
assist in distributing vaccines and other logistics to sites
from the district to sub-district levels to ensure their
availability (Fig. 2). Our observation of vaccination
Fig. 2 Root Cause Analysis (RCA) of successful implementation of MRC
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about 99% (95% CI 97.0–100) of the sessions (Table 1).
However, in all sessions we observed that there were in-
adequate quantities of soap, finger markers and cotton,
which are necessary commodities for administering
vaccines.
For the cold chain management of the MR vaccine,
cold storage capacity and other logistic-materials were
made available by EPI for the vaccine at the district and
sub-district levels. The EPI used other public-sector fa-
cilities to mitigate challenges regarding insufficient vac-
cine storage facilities at the national level. In the
meantime, managers at the district and sub-district
levels had collaborated with other local-level stake-
holders, including the local electricity department, ice-
cream factories, and local government authorities to en-
sure adequate amount of ice packs were available for
vaccine carriers. The EPI used freeze-tags to monitor the
temperature of ice-lined refrigerators, which were used
for storing large amounts of vaccines at the district and
sub-district levels. In this campaign, the EPI used vac-
cine vial monitors to ensure the quality of the vaccine.
However, during our observations of vaccination sessionwe noted that only about 54% (95% CI 46.1–62.3) of the
facilities used the appropriate ice packs (semi-frozen);
MR vaccine vials and carriers were available in all the fa-
cilities, except in the urban areas of Rajshahi (Table 1).
Availability of workforce and adaptability with a heavy
workload
A total of 67,900 vaccinators and 241,000 volunteers
were required to implement the MRC. The EPI ensured
the availability of an adequate workforce by involving
the private-sector medical colleges, nursing colleges, and
local health institutions. The MRC involved a wide var-
iety of roles, as noted by a national-level official stated:
It’s true that some of the posts of health workers
(Health Assistants) are vacant. Therefore, a large
workforce was needed for the MR campaign, and they
met the need for the required workforce by utilizing
multi-sector staff, such as Health Assistants, Family
Welfare Assistants, Health Inspectors, Family Planning
Inspectors, Sub-Assistant Community Medical Officers,
Medical Assistants, Family Welfare Visitors, and
Sanitary inspectors.
Table 1 Quality and adequacy of logistics, and quality of services provided during MR campaign
Parameter High-performing
division (Rajshahi) N = 72
Low-performing
division (Sylhet) N = 72
*p-value Total N = 144
Availability of logistic-materials
in the vaccination sessions % 95% CI % 95% CI % (95% CI)
Vaccine vial 98.6 97.0–100 100 – 0.314 99.3 (98.2–100)
Vaccine carrier 97.2 93.9–100 100 – 0.153 98.6 (96.4–100)
Diluents 100 – 100 – – 100
AD syringe 100 – 100 – – 100
Finger marker 62.5 44.1–80.9 47.2 40.1–54.4 0.065 54.9 (46.5–63.2)
Soap 13.9 0–28.1 4.2 0–8.6 0.043 9.0 (3.4–14.6)
Cotton 80.6 65.3–95.8 52.8 45.9–59.6 0.000 66.7 (52.7–80.7)
Quality and adequacy of logistics
Fully-melted ice pack 0.0 – 1.4 1.1–1.7 0.314 0.7 (0–2.1)
Semi-frozen ice pack 34.7 23.7–45.7 73.6 63.4–83.8 0.000 54.2 (46.1–62.3)
Registration form 33.3 5.4–61.3 38.9 30.0–47.8 0.484 36.1 (21.3–50.9)
Adequate MR vaccine supplies 86.1 80.0–92.2 90.3 82.6–98.0 0.435 88.2 (82.9–93.5)
Adequate needles or syringes 90.3 78.7–100 94.4 90.5–98.4 0.355 92.4 (85.9–98.8)
Adequate both MR vaccine and needles or syringes 94.4 87.8–100 97.2 94.6–99.9 0.402 95.8 (91.9–99.8)
Duration of session (Mean ± SD) 4.3 ± 1.4 h 4.0 ± 1.2 h 0.170 4.1 ± 1.3 h
Availability of firstline supervisor and volunteer
Firstline supervisor 62.5 37.3–87.7 43.1 32.8–53.3 0.020 52.8 (40.1–65.5)
Volunteer 94.4 90.6–98.3 50.0 39.8–60.2 0.000 72.2 (56.1–88.4)
Quality of services provided to individual children N = 462 N = 453 *p-value N = 915
% 95% CI % 95% CI % (95% CI)
Handwashing before vaccination 44.2 41.0–50.0 8.8 3.9–13.8 0.000 26.7 (16.0–37.3)
Top of the vaccine box /carrier snugly placed 90.9 86.0–95.8 77.7 68.8–86.6 0.000 84.4 (80.2–88.6)
Child’s finger marked after vaccination 94.7 92.4–97.0 70.1 60.5–79.6 0.000 82.4 (77.2–87.7)
Vaccinator put a tally after each vaccination 98.7 97.4–99.9 67.2 56.6–77.8 0.000 83.0 (77.8–88.1)
Information on adverse event/side-effects provided 5.1 2.9–7.2 6.2 4.4–8.1 0.471 5.6 (4.2–7.1)
Applied non-touch technique 100 – 99.6 99.1–99.9 0.174 99.8 (99.6–100)
Used AD syringes put into the safety box 99.1 98.5–99.7 95.8 91.1–100 0.000 97.5 (95.0–99.9)
* Fisher’s exact test
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viders for the MRC, the EPI developed a cascading train-
ing curriculum with 84% (95% CI 77.1–88.9) of the
service providers receiving training for 2 days and 3.3%
of the service providers receiving 3 days of training in
one division (Table 2). However, training was not held in
all districts and sub-districts as planned and the duration
of training was curtailed a number of times due to polit-
ical unrest.
Some challenges were also observed in the quality of
implementation of the MRC as service providers, in
some places, did not practice standard vaccination pro-
cedures, such as using soap every time, marking the fin-
ger of the vaccinated child, tallying vaccinated children
and informing caregivers about side-effects of the vac-
cine (Table 1). Additionally, some service providers hada heavy workload, working up to 3 hrs more than the
normal working hours per day. Our observations of vac-
cination sessions revealed that 6 persons, including vol-
unteers who managed the crowds, were required on
average, to vaccinate about 208 children (Table 3). In
our interviews, service providers reported that they had
acquired useful skills from their involvement in previous
immunization campaigns that they used to manage the
MR campaign-related workload.
Multiple partner involvement in developing advocacy
strategy and IEC materials for the campaign
MoHFW developed and implemented an advocacy strat-
egy to promote the campaign and ensure full participa-
tion and support from all concerned authorities,
including policy-makers from different ministries, top






Duration of training N = 60 N = 95 N = 155
% 95% CI % 95% CI % (95% CI)
One day 0.0 – 24.2 16.5–34.0 0.000* 14.8 (10.0–21.4)
Two days 96.7 87.2–99.2 75.8 66.0–83.5 83.9 (77.1–88.9)
Three days 3.3 0.8–12.8 0.0 – 1.3 (0.3–5.1)
Perception of provider about adequacy of training
Adequate 58.3 45.2–70.4 53.7 43.5–63.6 0.525 55.5 (47.5–63.2)
Reasons why training was inadequate N = 25 N = 44 p-value N = 69
% 95% CI % 95% CI % (95% CI)
Duration of training was short 100 – 100 – – 100
Training materials/logistics were insufficient 16.0 5.7–37.5 2.3 0.3–15.5 0.035 7.3 (3.0–16.6)
Training methods/techniques were not good 4.0 0.5–26.3 2.3 0.3–15.5 0.687 2.9 (−1.1–6.9)
Trainers were not good 0.0 – 15.9 7.5–30.5 0.035 10.1 (4.8–20.1)
Organizing campaign without hampering routine work N = 60 N = 96 p-value N = 156
% 95% CI % 95% CI % (95% CI)
Very successful 75.0 62.2–84.6 50.0 40.0–60.0 0.003* 59.6 (51.7–67.1)
Somewhat successful 23.3 14.1–36.0 47.9 38.0–58.0 38.5 (31.1–46.4)
Not successful 1.7 0.2–11.5 2.1 0.5–8.1 1.9 (0.6–5.9)
Caregivers’ perception regarding benefits of MR campaign N = 289 N = 285 p-value N = 574
% 95% CI % 95% CI % (95% CI)
Able to vaccinate child/children 77.50 72.3–82.0 78.3 73.0–82.7 0.817 77.9 (74.3–81.1)
Massive publicity motivates for vaccination 4.2 2.4–7.2 2.8 1.4–5.5 0.362 3.5 (2.3–5.3)
Aware about measles and rubella diseases 21.8 17.4–27.0 44.6 38.9–50.4 0.000 33.1 (29.4–37.1)
Reduces the fear of vaccination 2.8 1.4–5.5 3.2 1.6–6.0 0.779 3.0 (1.8–4.7)
Increases interest towards other vaccines 5.9 3.7–9.3 3.1 1.6–6.0 0.692 4.5 (3.1–6.6)
Changes attitude to go to the health centers for healthcare 6.6 3.7–9.5 0.7 0.2–2.8 0.000 3.7 (2.4–5.5)
Other 11.4 8.2–15.7 12.3 8.9–16.7 0.739 11.9 (9.4–14.8)
Decline to respond 2.4 1.2–5.0 2.8 1.4–5.5 0.170 2.6 (1.6–4.3)
Satisfaction of caregivers regarding MRC N = 289 N = 285 p-value N = 574
% 95% CI % 95% CI % (95% CI)
Unsatisfied 0.4 0–2.4 0.7 0.2–2.8 0.011* 0.5 (0.2–1.6)
Satisfied 76.8 71.6–81.3 85.3 80..6–88.9 81..0 (77.6–84.0)
Very satisfied 22.8 18.3–28.1 14.0 10.4–18.6 18.5 (15.5–21.9)
* Fisher’s exact test
Table 3 Average number of children vaccinated and average number of vaccinators available in each session






Total (N = 144)
Average ± SD
(95% CI)Average ± SD Average ± SD
Number of children vaccinated 175.0 ± 171.8 241.9 ± 309.8 0.112 208.4 ± 251.9 (166.9–249.9)
Number of vaccinators available 7.1 ± 3.8 4.2 ± 2.1 0.000 5.7 ± 3.4 (5.1–6.2)
** T-test
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bodies, public leaders, and development partners. This
strategy was adopted at the national, divisional, district,
City Corporation, local municipality, and upazila (sub-
district) levels in order to confirm the success of the
MRC. As part of this advocacy strategy, the EPI devel-
oped materials for information, education and commu-
nication (IEC) that were used from the national level to
the community level. Additionally, the EPI held advo-
cacy meetings with Bangladesh Medical Association (in-
cluding with renowned medical professionals), and the
Pediatric Association to advise them of the MRC and to
seek their support, including for disseminating informa-
tion to parents. Furthermore, advocacy meetings were
held with news editors from the press and electronic
media to obtain their support for the publication of arti-
cles and messages to help create favorable public aware-
ness and to counter instances of negative publicity, such
as the false information that unknown sources circulated
through short message service (SMS) to create panic re-
garding the poor quality of vaccines and the likelihood
of causing adverse effects (Fig. 2).
Difficulties occurred around the timing of advocacy
events, especially in hard-to-reach and remote areas. In
response to these challenges health workers used a var-
iety of communication channels to disseminate mes-
sages. For example, a health worker with experience in
hard-to-reach areas said:
We used mosques to make announcements regarding
campaign activities in hard-to-reach areas, and if
mosques were unavailable, we communicated with the
community leaders in order to disseminate our infor-
mation. Sometimes, we hired volunteers who lived in
those areas to help us. We met at the union offices in
order to carry out successful work.
Interviews with children’s caregivers also highlighted
that word-of-mouth and community announcements
through mosques and the involvement of Health Assis-
tants helped raise awareness in communities about the
MRC. As a result, about 81% (95% CI 77.6–84.0) of the
mothers expressed satisfaction with the campaign (Table
2) and about 78% (95% CI 74.3–81.1) reported that their
children were vaccinated through the campaign (Table 2).
Discussion
The MRC was highly successful, achieving a 90% cover-
age rate and increasing awareness about MR vaccine in
the communities [15]. The MRC did not disrupt the
routine EPI services in the country – a significant ac-
complishment considering that previous introductions of
new vaccines through mass campaigns in other settings
have had negative impacts on routine immunization[24]. Successful campaigns depend on the completion of
a number of key activities, including planning, budget-
ing, training, supervision, and monitoring [25]. Our
evaluation determined that several factors contributed to
the success of the MRC, including political commitment
on the part of the MoHFW, effective design of service
delivery, a committed health workforce, successful de-
mand generation, and the adaptive management capacity
of the EPI and its partners in addressing numerous
challenges.
Political commitment for the MRC came from the
highest levels of governance, as evidenced by the initia-
tive taken by the Minister of the MoHFW in adjusting
the MRC budget and releasing funds, which enabled
minimum interruption campaign launch. In other con-
texts, political commitment to improve health services
for women and children has been a critical factor in the
success of immunization programs [26, 27]. Similar to
other vaccination campaigns in Bangladesh, using both
institutional- and community- level service delivery
helped to achieve intended outcomes; for example, cov-
ering the drop-outs and community children in regular
outreach session [13].
Effective design of the campaign and rapid decision-
making at different levels of the EPI programme to ad-
just MRC implementation challenges also contributed to
successful implementation of the campaign. The EPI
was able to achieve the MRC implementation during a
period of political turbulence, by managing the supply of
vaccines and related logistics at the community level.
Moreover, long-standing partnerships with institutions
at the national, district and sub-district level, bolstered
EPI’s management capacity during planning and imple-
mentation of the MRC. Previous studies have also sug-
gested that support from partner organizations can help
boost campaigns, generate demand, manage adverse
events following immunization, and strengthen other
campaign activities [6, 28]. Our study also indicated that,
with the supports of the WHO and UNICEF, the
MoHFW managed several challenges including, timely
adjustment of vaccine stock-out and logistics supplies.
Timely access to accurate information and coordination
across multiple levels of the health system enabled rapid
identification of implementation problems and ability for
EPI and partners to respond quickly with mitigating
strategies [26]. The systematic identification of problems
by all relevant stakeholders may contribute to a success-
ful vaccination program [28].
Key factors behind successful vaccination campaigns
include the level of demand for a vaccine among the tar-
geted population and the ability of service providers to
meet it [29]. We observed a dedicated health workforce,
with a high level of satisfaction about their involvement
in the MRC. Activities designed to improve participation
Sarma et al. BMC Public Health          (2019) 19:925 Page 9 of 10in the campaign helped staff members increase their
ability to work under pressure and manage heavy work-
loads [30, 31]. Moreover, travel allowances, food, and
stationery motivated the staff members to perform better
[32]. These observations contrast to other those from
other studies which reported that using incentives may
lead to a culture of dependency among healthcare
workers and reduce their motivation to provide routine
vaccination and other health services [33].
Previous literature has found that religious beliefs, lack
of knowledge, fear of infertility and negative propaganda
[22] are the main reasons for people rejecting
immunization [34]. Implementation of a comprehensive
strategy for demand generation in the target population
is crucial to such large campaigns. We observed that ad-
vocacy activities at the national to sub-national levels in-
creased the community’s awareness of the MRC and
reduced the impact of negative propaganda around the
MR vaccine.
In terms of limitations, our evaluation covered only
two divisions which may not be enough to provide a
comprehensive understanding of the implementation
process of the MRC in the entire country. Moreover,
some of the findings from this study were derived from
a limited number of qualitative interviews which re-
duced the generalizability of the findings to other set-
tings. Despite these limitations, the strengths of the
study included using a range of innovative methods to
characterize the implementation process of the MRC,
for example, root cause analysis. Additionally, the study
provides a holistic understanding of the implementation
process of the MRC through a comprehensive triangula-
tion of findings with multiple data sources.
Conclusions
Overall, successful implementation of the MRC was
achieved through a high coverage of the MR vaccine [15]
among the children and youth aged 9months to 14 years,
demonstrating that the capacity of the EPI and the part-
nerships around immunization programs is very strong.
We recommend that the EPI programme and its partner
institutes work together to strengthen and sustain these
partnerships for future vaccine introductions and to
respond implementation challenges might occurred at dif-
ferent level of EPI programme, from national to commu-
nity level. Lessons learnt from vaccine introduction
campaigns of other countries are also of value in building
capacity for EPI in low-income countries.
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